H19 and familial pancreatic carcinoma: Similarly, many more lncRNAs are on the way to FDA approval and are going through different phases of clinical trials, e.g., the lncRNA H19 is at the stage of clinical trials for glioblastoma, ovarian, bladder, and pancreatic cancer.